Sign in to view content

Continuous submicrogram fluocinolone acetonide (FAc) therapy for the treatment of diabetic retinopathy

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2017

Related

Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA
W. Lloyd Clark, MD, FASRS
Annual Meeting Talks
2019
Effect of Fluocinolone Acetonide 0.2µg/day (ILUVIEN®) Implant on the Decision to Drive in Patients With Differential Control of DME
Seenu M. Hariprasad, MD
On Demand Cases, Courses, and Papers
2018
Diabetic Retinopathy Take Home Panel
Annual Meeting Talks
2020

Category: Diabetic Retinopathy

See more